The Advanced Therapies Congress focuses on tackling challenges at each stage of development to accelerate development of next generation therapies to benefit patients. We bring together decision makers from key biotech and pharma companies, putting forward a good ratio of buyers and sellers in our audience. With 8 tracks of content, the agenda covers everything from manufacturing, supply chain & logistics, pricing &market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells, regenerative medicine, and much more
